There are significant disparities with regards to incidence, timely diagnosis, access to
treatment, clinical trial participation and health care utilization that negatively impact …

Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …

Multiple myeloma (MM) is the most common hematologic malignancy in blacks. Some prior
studies suggest inferior survival in blacks; others suggest similar survival. Using the original …

Monoclonal gammopathy of undetermined significance is one of the most common pre-
malignant disorders. IgG and IgA monoclonal gammopathy of undetermined significance are …

First-degree relatives of patients with multiple myeloma are at increased risk for the disease,
but the contribution of pathogenic germline variants (PGV) in hereditary cancer genes to …

OBJECTIVE To define age-adjusted incidence trends in multiple myeloma (MM) in a well-
characterized population during a long period, given that some, but not all, studies have …

Obesity and black race have been associated with excess risk of multiple myeloma. The
association of obesity with monoclonal gammopathy of undetermined significance (MGUS) …

Cancer is known for its cellular changes contributing to tumour growth and cell proliferation.
As part of these changes, metabolic rearrangements are identified in several cancers …

Multiple myeloma (MM) is characterized by an uninhibited, clonal growth of plasma cells.
While first-degree relatives of patients with MM show an increased risk of MM, the genetic …

The associations between immune-related conditions and multiple myeloma (MM) and
monoclonal gammopathy of undetermined significance (MGUS) have previously been …